Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ian M Thompson

Showing results (171-180 of 484) with videos related to

Pageof 49
Sort By:
Cancer|May 31, 2013
The Prostate Cancer Prevention Trial risk calculator and the relationship between prostate-specific antigen and biopsy outcomeAndrew J Vickers, Daniel D Sjoberg, Donna P Ankerst, et al.
Current Urology Reports|May 5, 2005
Local and systemic therapy for patients with metastatic prostate cancer: should the primary tumor be treated?Edith D Canby-Hagino, Gregory P Swanson, E David Crawford, et al.
JAMA|January 18, 2006
Erectile dysfunction and subsequent cardiovascular diseaseIan M Thompson, Catherine M Tangen, Phyllis J Goodman, et al.
World Journal of Urology|November 23, 2017
Men with family history of prostate cancer have a higher risk of disease recurrence after radical prostatectomyMark Thalgott, Martina Kron, Johannes M Brath, et al.
Neoplasia (New York, N.Y.)|November 22, 2007
Regulation of Cox-2 by cyclic AMP response element binding protein in prostate cancer: potential role for nexrutineRita Ghosh, Gretchen E Garcia, Katherine Crosby, et al.
Urologic Oncology|February 7, 2012
Prostate cancer risk prediction in a urology clinic in MexicoYuanyuan Liang, Jamie C Messer, Christopher Louden, et al.
Cancer Epidemiology|October 23, 2019
Variations in prostate biopsy recommendation and acceptance confound evaluation of risk factors for prostate cancer: Examining race and BMICatherine M Tangen, Jeannette Schenk, Cathee Till, et al.
American Journal of Epidemiology|August 10, 2010
Diet, supplement use, and prostate cancer risk: results from the prostate cancer prevention trialAlan R Kristal, Kathryn B Arnold, Marian L Neuhouser, et al.
Plos One|October 3, 2012
Predictive value of Sp1/Sp3/FLIP signature for prostate cancer recurrenceRoble G Bedolla, Jingjing Gong, Thomas J Prihoda, et al.
World Journal of Urology|May 21, 2003
The selenium and vitamin E cancer prevention trialEric A Klein, Scott M Lippman, Ian M Thompson, et al.
Pageof 49

Showing results (171-180 of 484) with videos related to

Sort By:
Pageof 49
Cancer|May 31, 2013
The Prostate Cancer Prevention Trial risk calculator and the relationship between prostate-specific antigen and biopsy outcomeAndrew J Vickers, Daniel D Sjoberg, Donna P Ankerst, et al.
Current Urology Reports|May 5, 2005
Local and systemic therapy for patients with metastatic prostate cancer: should the primary tumor be treated?Edith D Canby-Hagino, Gregory P Swanson, E David Crawford, et al.
JAMA|January 18, 2006
Erectile dysfunction and subsequent cardiovascular diseaseIan M Thompson, Catherine M Tangen, Phyllis J Goodman, et al.
World Journal of Urology|November 23, 2017
Men with family history of prostate cancer have a higher risk of disease recurrence after radical prostatectomyMark Thalgott, Martina Kron, Johannes M Brath, et al.
Neoplasia (New York, N.Y.)|November 22, 2007
Regulation of Cox-2 by cyclic AMP response element binding protein in prostate cancer: potential role for nexrutineRita Ghosh, Gretchen E Garcia, Katherine Crosby, et al.
Urologic Oncology|February 7, 2012
Prostate cancer risk prediction in a urology clinic in MexicoYuanyuan Liang, Jamie C Messer, Christopher Louden, et al.
Cancer Epidemiology|October 23, 2019
Variations in prostate biopsy recommendation and acceptance confound evaluation of risk factors for prostate cancer: Examining race and BMICatherine M Tangen, Jeannette Schenk, Cathee Till, et al.
American Journal of Epidemiology|August 10, 2010
Diet, supplement use, and prostate cancer risk: results from the prostate cancer prevention trialAlan R Kristal, Kathryn B Arnold, Marian L Neuhouser, et al.
Plos One|October 3, 2012
Predictive value of Sp1/Sp3/FLIP signature for prostate cancer recurrenceRoble G Bedolla, Jingjing Gong, Thomas J Prihoda, et al.
World Journal of Urology|May 21, 2003
The selenium and vitamin E cancer prevention trialEric A Klein, Scott M Lippman, Ian M Thompson, et al.
Pageof 49